Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evolus Inc EOLS

Healthcare
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar... see more

Recent & Breaking News (NDAQ:EOLS)

ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Evolus, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - EOLS

Business Wire October 19, 2020

SHAREHOLDER ALERT: Lowey Dannenberg Files Securities Class Action Lawsuit Against Evolus, Inc. (Newport Beach, California) on Behalf of Investors Who Acquired Shares from February 1, 2019 to July 6, 2020, and Encourages Investors to Inquire About the Lead Plaintiff Position Before the December 15, 2020 Lead Plaintiff Deadline.

GlobeNewswire October 16, 2020

Evolus Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolus, Inc. To Contact The Firm

Newsfile October 14, 2020

Bragar Eagel & Squire, P.C. Is Investigating Evolus, Lizhi, Iovance Biotherapeutics, and Y-mAbs Therapeutics and Encourages Investors to Contact the Firm

GlobeNewswire October 9, 2020

Evolus Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolus, Inc. To Contact The Firm

Newsfile October 8, 2020

Evolus Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolus, Inc. To Contact The Firm

Newsfile October 6, 2020

ROSEN, LEADING INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Evolus, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - EOLS

Newsfile October 5, 2020

Evolus Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolus, Inc. To Contact The Firm

Newsfile October 3, 2020

SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

ACCESSWIRE IA September 24, 2020

EOLS LOSS NOTICE: Rosen Law Firm Announces Investigation of Securities Claims Against Evolus, Inc. - EOLS

Business Wire September 24, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

ACCESSWIRE IA September 23, 2020

Evolus Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolus, Inc. To Contact The Firm

Newsfile September 22, 2020

EVOLUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolus, Inc. To Contact The Firm

Newsfile September 18, 2020

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

ACCESSWIRE IA September 17, 2020

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

ACCESSWIRE IA September 16, 2020

EOLS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Evolus, Inc. Investors of Investigation

ACCESSWIRE IA September 16, 2020

Evolus Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolus, Inc. To Contact The Firm

Newsfile September 16, 2020

Evolus, Inc. Investors: Company Investigated by the Portnoy Law Firm

GlobeNewswire September 15, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

ACCESSWIRE IA September 15, 2020

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

Business Wire September 15, 2020